Response Biomed Corp RPBIF

RE: RE: RE: RE: RE: $8 Million Private Placement

[dimar66]

I agree with a lot of what you say about RBM being a good investment, it is why I am here; unlike you I did not buy any private placement but purchased on the open market a substantial number of shares so although I have lost I have not lost as much as you.  The reason why we are invested here are the same a why Orbimed  wants to come aboard.  -- the potential is great.  The price Orebimed is paying is a steal and I thing they would do much better considering the value  here -  $1.50 a share would be a better price.  I don't see what the share roll back has to to do with this financing, how it is connected, unless it was done  to ram the price down in disregard to  interests of current shareholders.  Why not finance first and role-back second?  I think the shareholders should reject this offer and send the BOD back to the table and defend the value in this company rather than just give it away.  Orbimed are smart business people they will still see the investment value here just like we did at that price

It is obvious that Roche isn't doing very well with Ramp sales, you don't have to be on the inside to see that and this whole CLIA waiver has gone sideways.  This a funning deal when you think about because the Ramp 200 is multi-port device good for larger care institutions, Roche wanted it designed that way,  You wouldn't put a Ramp 200 in a doctors office because they don't need the capacity, it just turns out that Roche has their own single port test platform.  I think Roche just wanted Ramp to fill a gap in their marketing program for the larger hospitals and use their own technology for everything else?